首页> 外国专利> Method of preparing an anti-serum albumin Fab-effector moiety fusion construct

Method of preparing an anti-serum albumin Fab-effector moiety fusion construct

机译:制备抗血清白蛋白Fab效应子部分融合构建体的方法

摘要

The present invention relates to antigen-binding fragment (Fab) and a Fab-effector fusion protein or polypeptide comprising thereof. The Fab of the present invention specifically binds to serum albumin and thereby has extended in vivo half-life. The Fab of the present invention is characterized by not having cysteine residues that are responsible for the interchain disulfide bond in CH1 domain and C kappa L domain as well. The Fab-effector fusion protein or polypeptide of the present invention can be produced in periplasm of E. coli with high yield, and has increased in vivo half-life. Further, the present invention provides E. coli strain which produces various kinds of Fab-effector fusion proteins or polypeptides, and a pharmaceutical composition comprising the fab-effector fusion proteins or polypeptides.
机译:本发明涉及抗原结合片段(Fab)和包含其的Fab效应子融合蛋白或多肽。本发明的Fab特异性结合血清白蛋白,从而延长了体内半衰期。本发明的Fab的特征在于在C H1 结构域和Cκ结构域中也没有负责链间二硫键的半胱氨酸残基。本发明的Fab效应子融合蛋白或多肽可以在I的周质中产生。大肠杆菌,产量高,并且体内半衰期延长。此外,本发明提供了 E。产生各种Fab效应融合蛋白或多肽的大肠杆菌菌株,以及包含fab效应融合蛋白或多肽的药物组合物。

著录项

  • 公开/公告号US10618953B2

    专利类型

  • 公开/公告日2020-04-14

    原文格式PDF

  • 申请/专利权人 APRILBIO CO. LTD.;

    申请/专利号US201715717528

  • 发明设计人 SANGHOON CHA;

    申请日2017-09-27

  • 分类号C07K16/18;C07K19;C12N15/09;C12N15/63;C12N15/67;C07K16/46;C07K14/61;C07K14/535;C07K14/565;C07K14/765;A61K38;A61K39;

  • 国家 US

  • 入库时间 2022-08-21 11:30:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号